Covidien receives FDA clearance for SILS Port multiple instrument access port
21 January 2009
Covidien's Surgical Devices business unit has received US FDA c;earance to market the its SILS Port multiple instrument access port for laparoscopic surgery through a single incision.
The SILS Port is a single, flexible port that can be fitted through a small incision in the umbilicus which results in a single 'hidden scar', a cosmetic advance over the multiple visible scars associated with standard multi-port laparoscopy. The port has the capacity for up to three laparoscopic instruments.
"SILS Port is the first device specifically indicated for multiple instrument access to the abdomen through a single incision,” said Scott Flora, President, Surgical Devices, Covidien. “We led the first surgical revolution with multi-port laparoscopic surgery and Covidien is now leading the way again with SILS procedures and the new SILS Port, innovations that offer surgeons an immediate advancement in patient care,” he added.
Laparoscopic procedures performed through a single incision are a significant evolution in the world of surgery. While laparoscopy traditionally offers better patient outcomes including less pain and improved cosmesis than the open approach, SILS procedures have the potential to dramatically extend these benefits. The SILS Port is scheduled for commercialization in the United States and Europe later this year.
Bookmark this page